On Air Now

Current Show

Greg Belfrage   6:00 AM - 9:00 AM

Call Greg at 336-1320 or toll free 800-228-4435

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1320 AM Sioux Falls, SD 107.9 FM Sioux Falls, SD

Weather

Current Conditions(Sioux Falls,SD 57104)

More Weather »
35° Feels Like: 25°
Wind: SSE 16 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Partly Cloudy/Wind 65°

Tonight

Mostly Clear 50°

Tomorrow

Few Showers 70°

Alerts

EU agency calls for curbs on GSK, Valeant epilepsy drug

LONDON (Reuters) - Use of an epilepsy drug developed by GlaxoSmithKline and Valeant Pharmaceuticals should be restricted to patients for whom other anti-epileptic medicines have proved inadequate or not tolerated, EU regulators said on Friday.

The European Medicines Agency said the move followed cases of abnormal coloring of the skin, nails, lips and eye tissues, including the retina, in some patients who took Trobalt.

It recommended a comprehensive eye examination should be performed at the start of treatment and at least every six months during treatment. Among 55 patients receiving Trobalt in long-term studies examined so far, 15 had retinal pigmentation, the agency added.

Abnormal coloring of the retina can result in impaired vision.

The Food and Drug Administration issued a similar warning about the drug - which is sold in the United States as Potiga - last month.

(Reporting by Ben Hirschler)

Comments